EXOZ vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

EXOZ

42.3
AI Score
VS
CLYM Wins

CLYM

51.6
AI Score

Investment Advisor Scores

EXOZ

42score
Recommendation
HOLD

CLYM

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric EXOZ CLYM Winner
Net Income -2.04M -27.22M EXOZ
Operating Income -1.80M -30.57M EXOZ
ROE 530.4% -11.4% EXOZ
ROA -57.3% -11.1% CLYM
Total Assets 3.56M 246.29M CLYM
Cash 66,533 44.11M CLYM
Current Ratio 0.50 31.45 CLYM
Free Cash Flow -1.47M -25.18M EXOZ

Relative Price Performance (Last 90 Days)

EXOZ 1M: -15.0% · 3M: -29.1% CLYM 1M: -27.3% · 3M: -17.6%

Current Technical Phase

EXOZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 40

RSI (14): 40.0 · Price: $5.77

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.3 · Price: $10.94

Fundamentals Snapshot

Metric EXOZ CLYM
Market Cap — —
Forward P/E 0.0 -10.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 1.0% —
Operating Margin 0.0% 0.0%
EPS -1.20 -0.79
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.